These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25034355)
1. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis. Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis. Li J; Chen X; Dai M; Huang S; Chen J; Dai S Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):543-553. PubMed ID: 28291627 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma. Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813 [TBL] [Abstract][Full Text] [Related]
4. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma. Nabih MI; Aref WM; Fathy MM Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109 [TBL] [Abstract][Full Text] [Related]
6. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis. Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma. Abu El Makarem MA; Abdel-Aleem A; Ali A; Saber R; Shatat M; Rahem DA; Sayed D Ann Hepatol; 2011; 10(3):296-305. PubMed ID: 21677331 [TBL] [Abstract][Full Text] [Related]
8. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis. Zhou Y; Yin X; Ying J; Zhang B BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma. Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis. Zhang J; Zhao Y; Yang Q Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448 [TBL] [Abstract][Full Text] [Related]
11. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis. Lu Q; Li J; Cao H; Lv C; Wang X; Cao S Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039435 [TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis. Yi X; Yu S; Bao Y Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771 [TBL] [Abstract][Full Text] [Related]
13. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. Duarte-Salles T; Misra S; Stepien M; Plymoth A; Muller D; Overvad K; Olsen A; Tjønneland A; Baglietto L; Severi G; Boutron-Ruault MC; Turzanski-Fortner R; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Bamia C; Pala V; Palli D; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez-Cantalejo E; Ardanaz E; Gavrila D; Dorronsoro M; Werner M; Hemmingsson O; Ohlsson B; Sjöberg K; Wareham NJ; Khaw KT; Bradbury KE; Gunter MJ; Cross AJ; Riboli E; Jenab M; Hainaut P; Beretta L Cancer Prev Res (Phila); 2016 Sep; 9(9):758-65. PubMed ID: 27339170 [TBL] [Abstract][Full Text] [Related]
14. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517 [TBL] [Abstract][Full Text] [Related]
15. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis. Xu C; Yan Z; Zhou L; Wang Y J Cancer Res Clin Oncol; 2013 Aug; 139(8):1417-24. PubMed ID: 23743582 [TBL] [Abstract][Full Text] [Related]
16. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma. Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis. Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340 [TBL] [Abstract][Full Text] [Related]
18. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening. Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937 [TBL] [Abstract][Full Text] [Related]
19. Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis. Xiang D; Fu L; Yang Y; Liu C; He Y BMC Gastroenterol; 2024 May; 24(1):178. PubMed ID: 38773451 [TBL] [Abstract][Full Text] [Related]
20. Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis. Sun T; Tang Y; Sun D; Bu Q; Li P Onco Targets Ther; 2018; 11():8925-8935. PubMed ID: 30573979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]